Our history

Bexa is the result of years of innovation across multiple disciplines.

1997

Dr. Jae Son develops his new capacitive tactile pressure sensor in the Harvard Robotics Lab and forms Pressure Profile Systems,Inc. (PPS)

1999

Researchers from multiple organizations and PPS pioneer the field of pressure elastography

2001

PPS and Dr. Son form Medical Tactile, Inc. and acquire Assurance Medical’s “BreastView”, the first concept of a pressure elastography device

2003

BreastView receives FDA 510(k) clearance for creating elastographic images of abnormal beast tissues

2006

Dr. Son and MTI replace the BreastView sensors with their proprietary shape-conforming, ultra sensitive array sensor, world-leading signal conditioning electronics and add the first algorithms converting capacitive sensor data into images

2007

MTI releases this new device, “SureTouch” to the market

2013

SureTouch internal technology has evolved through continuous upgrades and performed more than 200,000 examinations in theUSA and worldwide, including China, Italy, South Africa, and Australia

2015

MTI and Qualcomm collaborate to create SureTouchMobile, a smaller, more portable device with sensor arrays connecting wirelessly to a tablet computer

MTI completes first working prototype of secure, cloud-based system for centralizing data collection and review

2016

SureTouch wins the Patrick Soon Shiong Innovation Award

2017

Sure, Inc. (“Sure,” JoePeterson, MD, CEO) and investors acquire all SureTouch devices, technologies, rights, and intellectual property from MTI; David Ables of MTI becomes Sure’s CTO

SureTouch wins an ABBY award for innovation in healthcare delivery

2018

Sure updates clinical protocols, training programs, and market strategy

Geoff Bricker joins Sure from SOC Telemed (NASDAQ: TLMD) to lead IT

2019

SureView, the cloud-based operating ecosystem within which all devices operate and share data, is launched

Sure receives a new FDA 510K for the wireless version of SureTouch2019 - Dr. Mark Hiatt, noted physician executive and innovator, joins Sure as an Advisor

SureTouch receives regulatory clearance in Saudi Arabia from FDA-equivalent, MDMA

SureTouch receives regulatory clearances in Ecuador & Jordan

TSM Technologies inIndonesia receives Qualcomm’s endorsement as contract manufacturer of SureTouch sensor units

University Cancer Center Clinical Validation Study returns landmark results

2020

SureTouch receives regulatory clearance in Mexico from FDA-equivalent, COFEPRIS

Sunny Gupta, CEO andT achy on Systems leads the creation of machine learning and AI capacity for elastographic data into an evolving analysis

SureLearn, an online learning system supporting both remote and in-person didactic and practical training, is launched

Radiologists & primary care physicians begin investing in Sure

Quantify Health and Quantify Care become key commercialization partners in the US

2021

Robin Roberts of Novartis and COO of the Novartis Biome, joins the Sure Board of Directors

SURE begins a large-scale definitive clinical validation study with a leading US academic imaging department slated for completion in July of 2021

Intelense adapts their industry-leading automated video analysis and anomaly detection engine into new analysis and visualization algorithms for elastography data

The SureView AI system expands to include the ability to “dream”

The transformed SureTouch is re-released as Bexa

Thank you for taking the time to learn about Bexa

We’re working hard to continuously advance the sophistication of Bexa and to establish its role in the early detection of breast cancer.

Read a message from our CEO